Listed

bioAffinity Technologies, Inc.

BIAFNasdaqCIK 1712762IndustrialsFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.5m, Q2 FY2026
Operating income−$3.3m, Q2 FY2026
Net income−$3.4m, Q2 FY2026
bioAffinity Technologies, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k298Revenue, Q3 FY2023, three months to 2023-09-30$298.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure2,213Revenue, Q4 FY2023, three months to 2023-12-31$2.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001641172-25-001840. Derived: 12-month figure less the 9-month figure.Report this figure2,406Revenue, Q1 FY2024, three months to 2024-03-31$2.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure2,398Revenue, Q2 FY2024, three months to 2024-06-30$2.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure2,350Revenue, Q3 FY2024, three months to 2024-09-30$2.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure2,208Revenue, Q4 FY2024, three months to 2024-12-31$2.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure1,854Revenue, Q1 FY2025, three months to 2025-03-31$1.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure1,269Revenue, Q2 FY2025, three months to 2025-06-30$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure1,446Revenue, Q3 FY2025, three months to 2025-09-30$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure1,593Revenue, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure1,352Revenue, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure1,511Revenue, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Cost of revenue$k74.7Cost of revenue, Q3 FY2023, three months to 2023-09-30$74.7k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2023-11-14, accession 0001493152-23-040986.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$k224Gross profit, Q3 FY2023, three months to 2023-09-30$223.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2023-11-14, accession 0001493152-23-040986.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k330Research and development, Q3 FY2023, three months to 2023-09-30$330.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure433Research and development, Q4 FY2023, three months to 2023-12-31$432.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001641172-25-001840. Derived: 12-month figure less the 9-month figure.Report this figure394Research and development, Q1 FY2024, three months to 2024-03-31$393.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure402Research and development, Q2 FY2024, three months to 2024-06-30$402.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure274Research and development, Q3 FY2024, three months to 2024-09-30$274.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure391Research and development, Q4 FY2024, three months to 2024-12-31$390.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure367Research and development, Q1 FY2025, three months to 2025-03-31$367.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure311Research and development, Q2 FY2025, three months to 2025-06-30$311.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure331Research and development, Q3 FY2025, three months to 2025-09-30$330.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure374Research and development, Q4 FY2025, three months to 2025-12-31$374.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure350Research and development, Q1 FY2026, three months to 2026-03-31$349.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure362Research and development, Q2 FY2026, three months to 2026-06-30$361.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Selling, general and administrative$k2,024Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure2,214Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-31, accession 0001641172-25-001840. Derived: 12-month figure less the 9-month figure.Report this figure2,186Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure2,473Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure2,365Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$2.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure2,920Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$2.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure2,453Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure2,215Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure2,209Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure3,037Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$3.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure3,242Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$3.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure2,859Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$2.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Operating income$k(2,295)Operating income, Q3 FY2023, three months to 2023-09-30−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure(2,342)Operating income, Q4 FY2023, three months to 2023-12-31−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001840. Derived: 12-month figure less the 9-month figure.Report this figure(1,945)Operating income, Q1 FY2024, three months to 2024-03-31−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure(2,088)Operating income, Q2 FY2024, three months to 2024-06-30−$2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure(1,974)Operating income, Q3 FY2024, three months to 2024-09-30−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure(2,947)Operating income, Q4 FY2024, three months to 2024-12-31−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure(2,627)Operating income, Q1 FY2025, three months to 2025-03-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(2,516)Operating income, Q2 FY2025, three months to 2025-06-30−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure(2,293)Operating income, Q3 FY2025, three months to 2025-09-30−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure(3,137)Operating income, Q4 FY2025, three months to 2025-12-31−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure(3,617)Operating income, Q1 FY2026, three months to 2026-03-31−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(3,335)Operating income, Q2 FY2026, three months to 2026-06-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Interest expense$k8.8Interest expense, Q3 FY2023, three months to 2023-09-30$8.8k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001493152-23-040986.Report this figure25.3Interest expense, Q4 FY2023, three months to 2023-12-31$25.3k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-04-01, accession 0001493152-24-012358. Derived: 12-month figure less the 9-month figure.Report this figure23.6Interest expense, Q1 FY2024, three months to 2024-03-31$23.6k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-15, accession 0001493152-24-019615.Report this figure22.2Interest expense, Q2 FY2024, three months to 2024-06-30$22.2k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure21.6Interest expense, Q3 FY2024, three months to 2024-09-30$21.6k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure25.0Interest expense, Q4 FY2024, three months to 2024-12-31$25.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure15.5Interest expense, Q1 FY2025, three months to 2025-03-31$15.5k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure10.5Interest expense, Q2 FY2025, three months to 2025-06-30$10.5k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure5.4Interest expense, Q3 FY2025, three months to 2025-09-30$5.4k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure13.1Interest expense, Q4 FY2025, three months to 2025-12-31$13.1k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure14.7Interest expense, Q1 FY2026, three months to 2026-03-31$14.7k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure11.7Interest expense, Q2 FY2026, three months to 2026-06-30$11.7k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Income tax$k2.3Income tax, Q3 FY2023, three months to 2023-09-30$2.3k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure2.3Income tax, Q4 FY2023, three months to 2023-12-31$2.3k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0001641172-25-001840. Derived: 12-month figure less the 9-month figure.Report this figure3.7Income tax, Q1 FY2024, three months to 2024-03-31$3.7k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure5.4Income tax, Q2 FY2024, three months to 2024-06-30$5.4k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure2.6Income tax, Q3 FY2024, three months to 2024-09-30$2.6k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure8.7Income tax, Q1 FY2025, three months to 2025-03-31$8.7k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure29.0Income tax, Q2 FY2025, three months to 2025-06-30$29.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure3.2Income tax, Q3 FY2025, three months to 2025-09-30$3.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure3.2Income tax, Q4 FY2025, three months to 2025-12-31$3.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Net income$k(2,291)Net income, Q3 FY2023, three months to 2023-09-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure(2,373)Net income, Q4 FY2023, three months to 2023-12-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001641172-25-001840. Derived: 12-month figure less the 9-month figure.Report this figure(1,962)Net income, Q1 FY2024, three months to 2024-03-31−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure(2,110)Net income, Q2 FY2024, three months to 2024-06-30−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure(2,001)Net income, Q3 FY2024, three months to 2024-09-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure(2,967)Net income, Q4 FY2024, three months to 2024-12-31−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure(2,660)Net income, Q1 FY2025, three months to 2025-03-31−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(4,061)Net income, Q2 FY2025, three months to 2025-06-30−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure(5,051)Net income, Q3 FY2025, three months to 2025-09-30−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure(3,137)Net income, Q4 FY2025, three months to 2025-12-31−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure(3,631)Net income, Q1 FY2026, three months to 2026-03-31−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(3,366)Net income, Q2 FY2026, three months to 2026-06-30−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Diluted EPS$ per share(0.26)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure(0.19)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure(4.84)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$4.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figurenot reported(4.80)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$4.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(5.07)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$5.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure(4.74)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$4.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figurenot reported(0.81)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(0.64)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Basic EPS$ per share(0.26)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figurenot reported(0.20)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure(0.19)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure(4.84)Basic EPS, Q3 FY2024, three months to 2024-09-30−$4.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figurenot reported(4.80)Basic EPS, Q1 FY2025, three months to 2025-03-31−$4.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(5.07)Basic EPS, Q2 FY2025, three months to 2025-06-30−$5.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure(4.74)Basic EPS, Q3 FY2025, three months to 2025-09-30−$4.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figurenot reported(0.81)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(0.64)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure

Balance sheet

Cash and equivalents$2.4m, Q2 FY2026
Shareholders' equity$3.8m, Q2 FY2026
bioAffinity Technologies, Inc., balance sheet, quarterly
Line itemUnitFY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31period not labelled2025-05-07Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m2.8Cash and equivalents, FY2023, at 2023-12-31$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001641172-25-001840.Report this figure2.5Cash and equivalents, Q1 FY2024, at 2024-03-31$2.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001493152-24-019615.Report this figure0.8Cash and equivalents, Q2 FY2024, at 2024-06-30$801.3k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001493152-24-031943.Report this figure0.8Cash and equivalents, Q3 FY2024, at 2024-09-30$756.6k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure1.1Cash and equivalents, FY2024, at 2024-12-31$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001493152-26-010143.Report this figure0.4Cash and equivalents, Q1 FY2025, at 2025-03-31$444.7k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure3.3Cash and equivalents, period not labelled, at 2025-05-07$3.3m. XBRL concept us-gaap:Cash. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure0.8Cash and equivalents, Q2 FY2025, at 2025-06-30$802.8k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure7.7Cash and equivalents, Q3 FY2025, at 2025-09-30$7.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure6.4Cash and equivalents, FY2025, at 2025-12-31$6.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure3.1Cash and equivalents, Q1 FY2026, at 2026-03-31$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure2.4Cash and equivalents, Q2 FY2026, at 2026-06-30$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Current assets$m4.0Current assets, FY2023, at 2023-12-31$4.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001840.Report this figure3.9Current assets, Q1 FY2024, at 2024-03-31$3.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019615.Report this figure2.7Current assets, Q2 FY2024, at 2024-06-30$2.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-031943.Report this figure2.5Current assets, Q3 FY2024, at 2024-09-30$2.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure2.7Current assets, FY2024, at 2024-12-31$2.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001493152-26-010143.Report this figure1.9Current assets, Q1 FY2025, at 2025-03-31$1.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figurenot reported1.7Current assets, Q2 FY2025, at 2025-06-30$1.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure8.6Current assets, Q3 FY2025, at 2025-09-30$8.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure7.6Current assets, FY2025, at 2025-12-31$7.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure4.3Current assets, Q1 FY2026, at 2026-03-31$4.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure3.9Current assets, Q2 FY2026, at 2026-06-30$3.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Total assets$m8.2Total assets, FY2023, at 2023-12-31$8.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001641172-25-001840.Report this figure8.0Total assets, Q1 FY2024, at 2024-03-31$8.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001493152-24-019615.Report this figure6.7Total assets, Q2 FY2024, at 2024-06-30$6.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001493152-24-031943.Report this figure6.6Total assets, Q3 FY2024, at 2024-09-30$6.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure6.5Total assets, FY2024, at 2024-12-31$6.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001493152-26-010143.Report this figure5.5Total assets, Q1 FY2025, at 2025-03-31$5.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figurenot reported4.8Total assets, Q2 FY2025, at 2025-06-30$4.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure11.5Total assets, Q3 FY2025, at 2025-09-30$11.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure11.0Total assets, FY2025, at 2025-12-31$11.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure7.9Total assets, Q1 FY2026, at 2026-03-31$7.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure7.6Total assets, Q2 FY2026, at 2026-06-30$7.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Current liabilities$m2.2Current liabilities, FY2023, at 2023-12-31$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001641172-25-001840.Report this figure1.8Current liabilities, Q1 FY2024, at 2024-03-31$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019615.Report this figure2.3Current liabilities, Q2 FY2024, at 2024-06-30$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-031943.Report this figure2.5Current liabilities, Q3 FY2024, at 2024-09-30$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure3.1Current liabilities, FY2024, at 2024-12-31$3.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001493152-26-010143.Report this figure3.4Current liabilities, Q1 FY2025, at 2025-03-31$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figurenot reported2.6Current liabilities, Q2 FY2025, at 2025-06-30$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure2.4Current liabilities, Q3 FY2025, at 2025-09-30$2.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure2.9Current liabilities, FY2025, at 2025-12-31$2.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure3.2Current liabilities, Q1 FY2026, at 2026-03-31$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure2.7Current liabilities, Q2 FY2026, at 2026-06-30$2.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Total liabilities$m3.4Total liabilities, FY2023, at 2023-12-31$3.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001641172-25-001840.Report this figure2.8Total liabilities, Q1 FY2024, at 2024-03-31$2.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001493152-24-019615.Report this figure3.2Total liabilities, Q2 FY2024, at 2024-06-30$3.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001493152-24-031943.Report this figure3.4Total liabilities, Q3 FY2024, at 2024-09-30$3.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure3.9Total liabilities, FY2024, at 2024-12-31$3.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001493152-26-010143.Report this figure4.1Total liabilities, Q1 FY2025, at 2025-03-31$4.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figurenot reported6.9Total liabilities, Q2 FY2025, at 2025-06-30$6.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure2.6Total liabilities, Q3 FY2025, at 2025-09-30$2.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure3.7Total liabilities, FY2025, at 2025-12-31$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure4.3Total liabilities, Q1 FY2026, at 2026-03-31$4.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure3.9Total liabilities, Q2 FY2026, at 2026-06-30$3.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure
Short-term borrowings$mnot reportednot reportednot reported0.1Short-term borrowings, Q3 FY2024, at 2024-09-30$127.5k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figurenot reportednot reportednot reportednot reported0.3Short-term borrowings, Q3 FY2025, at 2025-09-30$260.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figurenot reportednot reportednot reported
Shareholders' equity$m4.9Shareholders' equity, FY2023, at 2023-12-31$4.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001493152-26-010143.Report this figure5.3Shareholders' equity, Q1 FY2024, at 2024-03-31$5.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure3.4Shareholders' equity, Q2 FY2024, at 2024-06-30$3.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure3.1Shareholders' equity, Q3 FY2024, at 2024-09-30$3.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure2.6Shareholders' equity, FY2024, at 2024-12-31$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure1.4Shareholders' equity, Q1 FY2025, at 2025-03-31$1.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figurenot reported(2.1)Shareholders' equity, Q2 FY2025, at 2025-06-30−$2.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure8.9Shareholders' equity, Q3 FY2025, at 2025-09-30$8.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure7.3Shareholders' equity, FY2025, at 2025-12-31$7.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure3.6Shareholders' equity, Q1 FY2026, at 2026-03-31$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure3.8Shareholders' equity, Q2 FY2026, at 2026-06-30$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure

Cash flow

Operating cash flow−$3.2m, Q2 FY2026
Capital expenditure$90.0k, Q2 FY2026
bioAffinity Technologies, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(1,533)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-045954. Derived: 9-month figure less the 6-month figure.Report this figure(1,616)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001641172-25-001840. Derived: 12-month figure less the 9-month figure.Report this figure(2,346)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure(1,532)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001641172-25-024163. Derived: 6-month figure less the 3-month figure.Report this figure(1,709)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001493152-25-023405. Derived: 9-month figure less the 6-month figure.Report this figure(1,677)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure(1,642)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(2,647)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001493152-26-036619. Derived: 6-month figure less the 3-month figure.Report this figure(2,480)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001493152-25-023405. Derived: 9-month figure less the 6-month figure.Report this figure(2,560)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure(3,227)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure(3,201)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001493152-26-036619. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$169. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001493152-24-045954. Derived: 9-month figure less the 6-month figure.Report this figure(13.4)Capital expenditure, Q4 FY2023, three months to 2023-12-31−$13.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001641172-25-001840. Derived: 12-month figure less the 9-month figure.Report this figure41.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$41.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure28.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$28.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001641172-25-024163. Derived: 6-month figure less the 3-month figure.Report this figure9.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$9.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001493152-25-023405. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$1. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure50.8Capital expenditure, Q1 FY2025, three months to 2025-03-31$50.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure13.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$13.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001493152-26-036619. Derived: 6-month figure less the 3-month figure.Report this figure(3.6)Capital expenditure, Q3 FY2025, three months to 2025-09-30−$3.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001493152-25-023405. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$1. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001493152-26-010143. Derived: 12-month figure less the 9-month figure.Report this figure5.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure90.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$90.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001493152-26-036619. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)5.23m, Q2 FY2026
bioAffinity Technologies, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares4.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-304,203,781 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001493152-23-040986.Report this figure8.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-318,433,689 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001493152-24-019615.Report this figure8.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-308,520,714 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001493152-24-031943.Report this figure8.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-308,696,554 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001493152-24-045954.Report this figure9.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-319,915,426 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001641172-25-010787.Report this figure11.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3011,389,308 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001641172-25-024163.Report this figure0.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30412,936 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure0.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31541,841 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure0.8Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30800,637 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure1.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,066,350 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001493152-25-023405.Report this figure4.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-314,494,752 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001493152-26-022044.Report this figure5.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-305,226,753 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure

Shares outstanding: 8.10mShares outstanding, period not labelled, at 2026-08-038,101,725 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-07, accession 0001493152-26-036619.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.